Recent 8-K filings for CABR
Highest-materiality recent filing
Nasdaq denies Caring Brands' continued listing; equity below $2.5M threshold
- Stockholders' equity of $2,091,324 was below Nasdaq's $2.5M minimum; alternative standards also not met.
- Nasdaq Staff denied continued listing on July 15, 2026, citing lack of definitive financing agreement for compliance plan.
-
Caring Brands appoints CFO Meadows and Chairman Wilson; prior CFO John departs
Brian John ceased as Interim CFO, principal accounting officer, director and Chairman on Sept 16, 2026; no disagreement cited.
-
Caring Brands raises $7.15M PIPE; pro forma equity $8.22M, seeks Nasdaq panel relief
Second PIPE closing on 9/11/26: 2,549.9 Series B Preferred shares plus A/B warrants for 2,549,900 shares each; gross proceeds $2,549,900.
-
Caring Brands appoints Brian R. Meadows as independent director; enters consulting pact
Brian R. Meadows appointed independent director effective Sept 4, 2026; he is CFO of Jones Soda Co. since 2025.
-
Caring Brands closes initial $4.6M of $9M private placement for marketing push
Initial closing of $4.6M in convertible preferred shares completed Sept 1, 2026 under $9M Purchase Agreement.
-
Caring Brands completes initial $4.6M private placement; expects $10.25M equity
Initial closing issued 4,600 Series B Preferred shares at $1,000 each for $4.6M gross proceeds.
-
Caring Brands enters up to $11M private placement of Series B convertible preferred and warrants
Issues up to 11,000 Series B Preferred shares at $1,000 each for gross proceeds up to $11,000,000.
-
Five issued U.S. patents now protect two core platforms: Hair Enzyme Booster (4 patents) and Photocil (1 patent).
-
Nasdaq denies Caring Brands' continued listing; equity below $2.5M threshold
Stockholders' equity of $2,091,324 was below Nasdaq's $2.5M minimum; alternative standards also not met.
-
Caring Brands raises $400K in PIPE; issues Series A Preferred convertible at $0.40/share
Gross proceeds $400K from 443 Series A Preferred shares (stated value $1,000) and 1,052,632 warrants at $0.40 exercise.
-
Caring Brands shareholders approve three proposals at special meeting
Proposal 1 (Additional Investment Right) approved: 4,457,375 for, 155,999 against.
-
Revised five-year licensing agreement effective May 21, 2026, expands territories to India (existing), LATAM, Russia, Australia, and New Zealand.
-
Caring Brands corrects record date in proxy statement - May 14, not May 12
Prior proxy statement (May 12, 2026) incorrectly listed May 12, 2026 as record date for annual meeting.
-
Caring Brands receives Nasdaq delisting notice for equity shortfall; stock continues trading
Stockholders' equity of $2,091,324 reported in FY2025 10-K, below Nasdaq's $2.5M minimum requirement.
-
Caring Brands reduces shareholder quorum to 33.33% and names Brian John interim CFO
Bylaw amendment cuts quorum for shareholder meetings from majority to 33.33% of outstanding shares.
-
Caring Brands closes $3.6M PIPE with Series A Preferred and warrants; redeems 6.25M insider shares
Issued 3,789.74 Series A Preferred shares (stated value $1,000 each) and 9,473,685 warrants at $0.40 exercise price for $3.6M gross.
-
Caring Brands receives two U.S. patents for hair enzyme booster technology
Two new U.S. patents granted Jan 2026 covering methods to increase sulfotransferase enzyme activity for topical hair loss treatments.
-
Caring Brands CFO Tyler Moore resigns; search for successor underway
Tyler Moore resigned as CFO on January 5, 2026, not due to any disagreement with the company.
-
Caring Brands enters exclusive global license for Emesyl nausea relief product
Licensed Emesyl OTC nausea product from Itonis; exclusive worldwide rights to manufacture, market, distribute.
-
Caring Brands raises $4M in IPO, lists on Nasdaq under 'CABR'
Sold 1,000,000 shares at $4.00; gross proceeds $4M, net ~$3.23M.
Materiality & sentiment trend
Max materiality 0.90 · Median 0.60 · Most common event other_material